Using data from the US Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System, RSI investigators collaborated on a study showing increased risks of myopericarditis – an inflammatory condition of the heart muscle – following mRNA COVID19 vaccination, with the highest risks seen in young males following a second vaccine dose. Similar findings have been reported by other investigators working with CDC health scientists. RSI investigators noted that the risk of myopericarditis is appreciably higher in individuals with COVID 19 than the risk associated with vaccination.
More RSI News
Using data from the US Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System, RSI investigators collaborated on a study showing increased risks of…
Read News Item
Following previous work on the potential risk of acute liver failure associated with quinolone antibiotics, RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel…
Read News Item
The International Aluminium Institute (IAI) recently commissioned Climate Risk Institute (CRI) and Risk Sciences International (RSI) to produce a series of informational tools evaluating and…
Read News Item
Quinolones, are a class of widely used and popular powerful antibiotics with broad coverage. RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski,…
Read News Item